February 20, 2017 9:37 AM ET

Biotechnology

Company Overview of Capricor Therapeutics, Inc.

Company Overview

Capricor Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of novel therapeutics primarily for the treatment of cardiovascular diseases. The company’s development stage drug candidates for cardiovascular diseases include CAP-1002 and enderitide, which are in Phase II clinical trials, as well as CAP-1001, which has completed Phase I clinical trial; and CU-NP and CSps. It is also developing Exosomes for the treatment of cardiovascular and non-cardiovascular diseases. The company was founded in 2005 and is headquartered in Beverly Hills, California.

8840 Wilshire Boulevard

2nd Floor

Beverly Hills, CA 90211

United States

Founded in 2005

29 Employees

Phone:

310-358-3200

Key Executives for Capricor Therapeutics, Inc.

Co-Founder, Chief Executive Officer, President and Director
Age: 53
Total Annual Compensation: $232.9K
Executive Vice President, General Counsel and Secretary
Age: 63
Total Annual Compensation: $254.2K
Chief Medical Officer
Age: 51
Total Annual Compensation: $104.2K
Compensation as of Fiscal Year 2015.

Capricor Therapeutics, Inc. Key Developments

Capricor Therapeutics Terminate License Agreement with the Mayo Clinic

Capricor Therapeutics, Inc. announced that it has elected to terminate its license agreement with the Mayo Clinic relating to natriuretic peptide receptor agonists, including Cenderitide.

Capricor Therapeutics, Inc. Presents at 19th Annual BIO CEO & Investor Conference, Feb-14-2017 01:30 PM

Capricor Therapeutics, Inc. Presents at 19th Annual BIO CEO & Investor Conference, Feb-14-2017 01:30 PM. Venue: The Waldorf Astoria New York, 301 Park Avenue, New York, NY 10022, United States. Speakers: Leland J. Gershell, Chief Financial Officer and Principal Financial Officer.

Capricor Therapeutics, Inc. Presents at 28th Annual Piper Jaffray Healthcare Conference, Nov-30-2016 04:00 PM

Capricor Therapeutics, Inc. Presents at 28th Annual Piper Jaffray Healthcare Conference, Nov-30-2016 04:00 PM. Venue: The Lotte New York Palace, 50th St. and Madison Avenue, New York, New York, United States. Speakers: Linda Marban, Co-Founder, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Capricor Therapeutics, Inc., please visit www.capricor.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.